452 Participants Needed

Online Pain Coping Skills Training for Joint Pain in Breast Cancer Survivors

Recruiting at 1 trial location
CR
RO
ZH
Overseen ByZahra Hosseinian
Age: 18+
Sex: Female
Trial Phase: Phase 3
Sponsor: Northwestern University
Must be taking: AI therapy
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Pivotal Trial (Near Approval)This treatment is in the last trial phase before FDA approval
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if an online program can help women with joint pain, a common side effect of certain breast cancer medications, feel better and manage their pain more effectively. Participants will either receive education about their medication and joint pain or receive that education plus access to an online pain coping skills training program. The trial will compare the two groups to see if the online program improves pain, emotional well-being, and medication adherence. Women who have completed primary treatment for stage I-III breast cancer, are on aromatase inhibitor therapy, and experience frequent joint pain may be suitable for this study. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants a chance to contribute to potentially groundbreaking treatment advancements.

Will I have to stop taking my current medications?

The trial does not require you to stop taking your current medications. However, if you are taking pain relievers, you need to be on a stable dose for at least 14 days before joining the study and should not plan to increase the dose during the study. You can discuss any changes with your doctor.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that online training for coping with pain has been well-received. For instance, one study found that participants experienced less pain and required fewer pain medications. They also gained confidence in managing their pain and adopted better coping strategies. This suggests the training is safe and could benefit those experiencing joint pain from AI medications used to treat breast cancer. No major negative side effects have been reported from the training itself, indicating it is likely a safe option for those seeking better pain management.12345

Why are researchers excited about this trial?

Researchers are excited about the Online Pain Coping Skills Training for joint pain in breast cancer survivors because it offers a novel, digital approach to managing pain without medication. Unlike standard treatments that often rely on pain medications or physical therapy, this online program empowers patients with cognitive and behavioral skills to manage their pain effectively. The program's interactive nature and convenience allow participants to access it from home, making it accessible even for those with busy schedules or limited mobility. By potentially reducing pain-related interference with daily activities, this method represents a promising shift towards more patient-centered and self-managed care.

What evidence suggests that this trial's treatments could be effective for joint pain in breast cancer survivors?

This trial will compare two approaches for managing joint pain in breast cancer survivors taking aromatase inhibitors (AI). One group will receive an educational booklet about AI side effects and management strategies. Another group will receive both the educational booklet and access to an online pain coping skills training program. Research has shown that online training for pain management can help breast cancer survivors who experience joint pain from AIs. Specifically, studies found that participants who learned these skills reported less pain and improved pain management. They also felt more confident in managing their pain and required fewer pain medications. Additionally, these programs enhanced their emotional well-being and overall quality of life. Early results suggest that learning these skills online could effectively manage AI-related pain and improve daily life.23467

Are You a Good Fit for This Trial?

This trial is for postmenopausal women over 18 with Stage I-III hormone receptor positive breast cancer, who've finished primary treatment and are on stable AI therapy experiencing joint pain. They must be English-speaking, able to use digital devices for online training, and likely to complete the study.

Inclusion Criteria

I am currently on AI therapy (letrozole, exemestane, or anastrozole).
My joint or muscle pain started or got worse after beginning AI therapy.
My pain medication dose has been stable for the last 2 weeks and I don't plan to increase it during the study.
See 10 more

Exclusion Criteria

Have diagnosed or suspected condition that would interfere with informed consent or completion of study activities (e.g., significant impairment in cognition or uncorrected hearing/vision)
I am postmenopausal because of medical treatment, not natural causes.
I had major surgery less than 8 weeks ago or minor surgery recently, as approved.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive education about AIs and arthralgia, with or without access to an online pain coping skills training program, completed over 8 to 10 weeks.

8-10 weeks
3 meetings (virtual) in the first month

Follow-up 1

Participants' medication adherence is monitored using electronic pill bottles.

10-14 weeks

Follow-up 2

Participants are monitored for changes in menopause-specific quality of life.

22-26 weeks

Follow-up 3

Participants are monitored for changes in pain, emotional distress, sleep disturbance, and medication adherence.

34-38 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Education
  • Online Pain Coping Skills Training
Trial Overview The trial tests if an online pain coping skills program can reduce pain severity from AI medication in breast cancer survivors, improve their quality of life, emotional distress, sleep issues, menopause symptoms and adherence to AI medications.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Education + Online Pain Coping Skill TrainingExperimental Treatment2 Interventions
Group II: EducationActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Northwestern University

Lead Sponsor

Trials
1,674
Recruited
989,000+

Duke University

Collaborator

Trials
2,495
Recruited
5,912,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Published Research Related to This Trial

An 8-week web-based pain coping skills training (PCST) program was found to be highly acceptable to cancer patients, providing both emotional and physical benefits, which could improve pain management for those with cancer-related bone pain.
Healthcare providers expressed support for the web-based PCST program, suggesting that it could be effectively integrated into clinical care if barriers such as provider familiarity and patient workload are addressed.
A qualitative study of patient and provider perspectives on using web-based pain coping skills training to treat persistent cancer pain.Rini, C., Vu, MB., Lerner, H., et al.[2020]
The Meaning-Centered Pain Coping Skills Training (MCPC) intervention was found to be feasible and acceptable for 30 participants with stage IV cancer, with a high completion rate of 90% for intervention sessions and 87% for post-intervention assessments.
Participants reported significant improvements in pain severity, pain interference, and spiritual well-being after the intervention, along with high satisfaction levels, indicating that MCPC could be a beneficial approach for managing pain in advanced cancer patients.
Meaning-Centered Pain Coping Skills Training: A Pilot Feasibility Trial of a Psychosocial Pain Management Intervention for Patients with Advanced Cancer.Winger, JG., Ramos, K., Kelleher, SA., et al.[2023]
Educational interventions for healthcare professionals improve their knowledge and attitudes towards cancer pain management, but this does not always lead to better patient outcomes.
Targeted educational programs for patients have been shown to improve their outcomes, suggesting that patient education is crucial, although the exact mechanisms of these improvements are still unclear.
Education in cancer pain management.Bennett, MI., Flemming, K., Closs, SJ.[2021]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/39706331/
Web-Based Pain Coping Skills Training (PCST) for Managing ...This trial aims to fill a gap in evidence-based behavioral pain interventions for breast cancer survivors with AI-associated arthralgia.
Web-Based Pain Coping Skills Training (PCST) for ...This trial aims to fill a gap in evidence-based behavioral pain interventions for breast cancer survivors with AI-associated arthralgia.
Pain Coping Skills Training to Improve Pain and Poor ...This clinical trial evaluates the effect of an online pain coping skills training program (painTRAINER) in combination with enhanced usual care.
Web-based Pain Coping Skills Training for Breast Cancer ...The main goal of this clinical trial is to test benefits of completing online pain coping skills training program in women who have been diagnosed with ...
Effect of Pain Coping Skills Training on ...Both conditions led to improvements in pain, pain medication use, pain self-efficacy, and coping skills use, and 5-session PCST showed the greatest benefits.
Web-based Pain Coping Skills Training for Breast Cancer ...The main goal of this clinical trial is to test benefits of completing online pain coping skills training program in women who have been diagnosed with ...
Online Pain Coping Skills Training for Joint Pain in Breast ...The main goal of this clinical trial is to test benefits of completing online pain coping skills training program in women who have been diagnosed with ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security